Granocyte 13.4 Mio (Lenograstim Vials) 13.4 Mio

Granocyte 13.4 Mio is a prescription medication containing lenograstim, used to stimulate white blood cell production. It is commonly prescribed to support patients undergoing chemotherapy or bone marrow transplants. This vial form is designed for subcutaneous or intravenous administration.

Strength

13.4 Mio

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Sanofi-Aventis Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lenograstim is primarily used to reduce the duration of neutropenia, a condition marked by low white blood cell counts, which can increase infection risk. It is often prescribed to patients receiving chemotherapy or those preparing for stem cell transplants. This medication helps the body recover white blood cells more quickly after treatment.

Side Effects

After administration, lenograstim works by stimulating the bone marrow to produce more neutrophils, a type of white blood cell essential for fighting infections. Patients may notice improved energy levels as their white blood cell counts rise. Some individuals report mild discomfort at the injection site following administration.

Precautions & Warnings

Store Granocyte 13.4 Mio vials at room temperature, away from direct sunlight and moisture. Keep the medication out of reach of children and pets. Always check the vial for particles or discoloration before use. Discard any unused portion after the prescribed dose is prepared.

Avoid Interactions

Lenograstim may interact with certain chemotherapy drugs, potentially altering their effects. Avoid alcohol during treatment, as it may impact white blood cell recovery. Consult a healthcare provider before combining this medication with other drugs, especially those affecting the immune system.

Frequently Asked Questions

It is used to stimulate white blood cell production in patients undergoing chemotherapy or bone marrow transplants.

It is typically given as an injection under the skin or into a vein, as directed by a healthcare professional.

Common effects may include mild pain at the injection site or temporary bone or muscle discomfort.

It should only be used under medical supervision, especially for patients with certain blood disorders or infections.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.